Thus, BC200 was not detected in normal breast tissue or benign breast tumors but was highly expressed in all invasive breast cancer (Iacoangeli et al. 2004) and in peripheral blood of invasive breast cancer patients due to the presence of circulating tumor cells (Iacoangeli et al. 2018). Here, BCYRN1 is linked to neoplasm.